MAGE-3 (191-205)

MAGE-3 (191-205) is a synthetic peptide fragment derived from the melanoma-associated antigen 3 (MAGE-3) protein, corresponding to amino acids 191 through 205 of the full-length sequence. As a member of the MAGE family, this peptide represents a well-characterized epitope commonly studied in the context of tumor immunology and antigen presentation. Its defined sequence and immunological relevance make it a valuable reagent for research focused on antigen processing, T-cell recognition, and peptide-MHC binding dynamics. The biochemical properties of MAGE-3 (191-205) enable precise interrogation of peptide-protein interactions and immune response mechanisms in vitro, supporting both fundamental and applied studies in cellular immunology and cancer biology.

Epitope mapping: Researchers utilize the MAGE-3 (191-205) peptide to map T-cell epitopes and dissect immune recognition events at the molecular level. By presenting this peptide to T cells in vitro, scientists can identify specific T-cell receptors that recognize the MAGE-3 epitope, facilitating a deeper understanding of antigen specificity and T-cell repertoire diversity. Such mapping efforts are crucial for elucidating the determinants of immunogenicity and for designing targeted immunological assays.

Antigen presentation studies: The defined sequence of this peptide provides a controlled system for investigating the mechanisms of major histocompatibility complex (MHC) class I and II presentation. By loading MAGE-3 (191-205) onto antigen-presenting cells or synthetic MHC molecules, researchers can analyze peptide binding affinities, stability, and presentation efficiency. These studies are instrumental in deciphering the rules governing peptide selection and display by MHC molecules, which are central to adaptive immune responses.

T-cell activation assays: The MAGE-3 (191-205) fragment serves as a standard stimulus in functional assays designed to assess T-cell activation, cytokine production, and cytotoxicity. Its use enables precise quantification of antigen-specific T-cell responses, allowing researchers to evaluate the potency and specificity of immune effector functions. Such assays are particularly valuable for characterizing immune recognition in tumor models and for validating the immunogenicity of candidate peptides in preclinical research.

Peptide-MHC binding analysis: The sequence-defined nature of MAGE-3 (191-205) makes it an optimal substrate for in vitro binding studies with recombinant MHC molecules. By assessing the affinity and kinetics of peptide-MHC interactions, scientists can generate binding profiles that inform the design of novel immunological reagents and contribute to predictive models of antigen presentation. These analyses support the rational selection of peptides for immunological studies and vaccine research.

Peptide synthesis validation: As a reference standard, the MAGE-3 (191-205) peptide is frequently employed to validate synthetic methodologies and analytical protocols in peptide chemistry laboratories. Its well-characterized sequence and established use in immunological assays make it an ideal candidate for assessing the fidelity of peptide synthesis, purification, and quality control processes. This application is essential for ensuring the reproducibility and reliability of peptide-based research tools used in immunology and cancer research.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L